ACTN4 and non-small cell lung carcinoma: We are currently considering the clinical application of ACTN4 measurement by using IHC or FISH with a specific antibody or fluorescent DNA probe, respectively, for analysis of ACTN4 levels in surgical specimens of early stage NSCLC.